Prodotti Divulgativi

Titolo File
Diagnostic and Therapeutic Approaches in Italian Hospitals:Adjuvant and Metastatic Therapy in Melanoma Chiarion-Sileni V.,Guida M.,Romanini A.,Bernengo M.G.,Ascierto P.,Queirolo P.,Mandalà M.,Maio M.,Ferraresi V.,Stanganelli I.,Testori A.,Ridolfi R.

113.79 Kb
Diagnostic and Therapeutic Approaches in Italian Hospitals:Adjuvant and Metastatic Therapy in Melanoma Chiarion-Sileni V.,Guida M.,Romanini A.,Bernengo M.G.,Ascierto P.,Queirolo P.,Mandalà M.,Maio M.,Ferraresi V.,Stanganelli I.,Testori A.,Ridolfi R.
Pubblicazioni IMI

72.9 Kb
Pubblicazioni IMI
Management of Small and Intermediate Congenital Nevi: A Nationwide Survey in Italy Stanganelli I.,Ascierto P.,Bono R.,De Giorgi V.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.

111.43 Kb
Management of Small and Intermediate Congenital Nevi: A Nationwide Survey in Italy Stanganelli I.,Ascierto P.,Bono R.,De Giorgi V.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.
Author and Subject Index Vol. 226, Suppl. 1,2013

43.29 Kb
Author and Subject Index Vol. 226, Suppl. 1,2013
Melanoma Management in Italy: Learning from Practice. A survey from the Intergruppo Melanoma Italiano Naldi L. Dermatology 2013;226 (suppl 1):IV Preface

52.8 Kb
Melanoma Management in Italy: Learning from Practice. A survey from the Intergruppo Melanoma Italiano Naldi L. Dermatology 2013;226 (suppl 1):IV  Preface
Follow-Up of Melanoma: A Survey of Italian Hospitals Testori A.,Chiarion-Sileni V.,Stanganelli I.,Rossi C.R.,Di Filippo F.,Ridolfi R.,Parmiani G.,Gandini S.,Soteldo J.

134.76 Kb
Follow-Up of Melanoma: A Survey of Italian Hospitals Testori A.,Chiarion-Sileni V.,Stanganelli I.,Rossi C.R.,Di Filippo F.,Ridolfi R.,Parmiani G.,Gandini S.,Soteldo J.
Impact of Mole Mapping in the Italian Health System Stanganelli I.,Ascierto P.,Bono R.,De Giorgi V.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.

103.32 Kb
Impact of Mole Mapping in the Italian Health System Stanganelli I.,Ascierto P.,Bono R.,De Giorgi V.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.
Melanoma Task Force (META) Project in Italy: Methodology Mingozzi E.,Fregosi S.,Gandini S.,Stanganelli I.,Chiarion-Sileni V.,Testori A.

65.35 Kb
Melanoma Task Force (META) Project in Italy: Methodology Mingozzi E.,Fregosi S.,Gandini S.,Stanganelli I.,Chiarion-Sileni V.,Testori A.
Surgical Management of Suspicious Melanocytic Lesions in Italy De Giorgi V.,Ascierto P.,Bono R.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.,Stanganelli I.

113.79 Kb
Surgical Management of Suspicious Melanocytic Lesions in Italy De Giorgi V.,Ascierto P.,Bono R.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.,Stanganelli I.
Surgical Treatment of Melanoma: A Survey of Italian Hospitals Testori A.,Chiarion-Sileni V.,Stanganelli I.,Rossi C.R.,Di Filippo F.,Ridolfi R.,Parmiani G.,Gandini S.,Soteldo J.

84.22 Kb
Surgical Treatment of Melanoma: A Survey of Italian Hospitals Testori A.,Chiarion-Sileni V.,Stanganelli I.,Rossi C.R.,Di Filippo F.,Ridolfi R.,Parmiani G.,Gandini S.,Soteldo J.
Diagnostic Services for Melanoma in Italy Stanganelli I.,Ascierto P.,Bono R.,De Giorgi V.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.

105.16 Kb
Diagnostic Services for Melanoma in Italy Stanganelli I.,Ascierto P.,Bono R.,De Giorgi V.,Pimpinelli N.,Chiarion-Sileni V.,Palmieri G.,Pizzichetta M.A.,Testori A.
Discrepant alterations in main candidate genes among multiple primary melanomas

Colombino M, Sini M, Lissia A, De Giorgi V, Stanganelli I, Ayala F, Massi D, Rubino C, Manca A, Paliogiannis P, Rossari S, Magi S, Mazzoni L, Botti G, Capone M, Palla M, Ascierto PA, Cossu A, Palmieri G1; Italian Melanoma Intergroup (IMI).                                                         J Transl Med. 2014 May 8;12:117

244.75 Kb
Discrepant alterations in main candidate genes among multiple primary melanomas
Standardization and quality control of surgical treatment of cutaneous melanoma: looking for consensus of the Italian melanoma intergroup.

Sommariva A, Clemente C, Rossi CR.                                                                                 Eur J Surg Oncol. 2015 Jan;41(1):148-56.

244.75 Kb
Standardization and quality control of surgical treatment of cutaneous melanoma: looking for consensus of the Italian melanoma intergroup.
Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis.

Pizzichetta MA, Kittler H, Stanganelli I, Bono R, Cavicchini S, De Giorgi V, Ghigliotti G, Quaglino P, Rubegni P, Argenziano G, Talamini R; Italian Melanoma Intergroup.                       Br J Dermatol. 2015 Jul;173(1):106-14.

541.26 Kb
Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis.
Meetings from the Italian Melanoma Intergroup, January 2009-December 2010 Editor(s): Testori A. (Milan) Chiarion-Sileni V. (Padua) Stanganelli I. (Meldola) Title Page/Table of Contents

84.13 Kb
Meetings from the Italian Melanoma Intergroup, January 2009-December 2010 Editor(s): Testori A. (Milan) Chiarion-Sileni V. (Padua) Stanganelli I. (Meldola)  Title Page/Table of Contents
Clinical genetic testing for familial melanoma in Italy: a cooperative study

Bruno W, Ghiorzo P, Battistuzzi L, Ascierto PA, Barile M, Gargiulo S, Gensini F, Gliori S, Guida M, Lombardo M, Manoukian S, Menin C, Nasti S, Origone P, Pasini B, Pastorino L, Peissel B, Pizzichetta MA, Queirolo P, Rodolfo M, Romanini A, Scaini MC, Testori A, Tibiletti MG, Turchetti D, Leachman SA, Bianchi Scarrà G; IMI, Italian Melanoma Intergroup. J Am Acad Dermatol. 2009 Nov;61(5):775-82

585.26 Kb
Clinical genetic testing for familial melanoma in Italy: a cooperative study
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients

Chiarion-Sileni V, Del Bianco P, De Salvo GL, Lo Re G, Romanini A, Labianca R, Nortilli R, Corgna E, Dalla Palma M, Lo Presti G, Ridolfi R; Italian Melanoma Intergroup (IMI). Eur J Cancer. 2003 Jul;39(11):1577-85.

230.67 Kb
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients
Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens

Chiarion-Sileni V, Guida M, Ridolfi L, Romanini A, Del Bianco P, Pigozzo J, Brugnara S, Colucci G, Ridolfi R, De Salvo GL; Italian Melanoma Intergroup (IMI). Br J Cancer. 2011 Jun 7;104(12):1816-21

433.89 Kb
Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls

Casula M, Alaibac M, Pizzichetta MA, Bono R, Ascierto PA, Stanganelli I, Canzanella S, Palomba G, Zattra E; Italian Melanoma Intergroup (IMI), Palmieri G. BMC Dermatol. 2009 Jul 22;9:7. doi: 10.1186/1471-5945-9-7

313.92 Kb
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy

Casula M, Muggiano A, Cossu A, Budroni M, Caracò C, Ascierto PA, Pagani E, Stanganelli I, Canzanella S, Sini M, Palomba G; Italian Melanoma Intergroup (IMI), Palmieri G. BMC Cancer. 2009 Oct 3;9:352. doi: 10.1186/1471-2407-9-352

1258.35 Kb
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy
Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity

Pagnanelli G, Bono R, Pizzichetta MA, Talamini R, Ascierto PA, Testori A, Stanganelli I; ItalianMelanoma Intergroup (IMI). Anticancer Res. 2007 Jul-Aug;27(4C):2939-44.

57.02 Kb
Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity
   

Utility

Fattori di Rischio

IMI e Associazioni di Pazienti

Iniziative e informazioni per i pazienti

MIRALMELANOMA

 

 

Leaflet AppMELANOMI

 

 

L'informazione nel Melanoma

scopri come
diventare
un socio IMI

Maggiori dettagli ›
pdfl'esperto rispondeNella sezione Forum
sempre a disposizione
uno dei nostri
specialisti IMI

Contatta l'esperto ›

consulta la sezione
con le offerte di lavoro

Clicca qui ›